Your browser doesn't support javascript.
loading
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Bravo, Lulu; Smolenov, Igor; Han, Htay Htay; Li, Ping; Hosain, Romana; Rockhold, Frank; Clemens, Sue Ann Costa; Roa, Camilo; Borja-Tabora, Charissa; Quinsaat, Antoinette; Lopez, Pio; López-Medina, Eduardo; Brochado, Leonardo; Hernández, Eder A; Reynales, Humberto; Medina, Tatiana; Velasquez, Hector; Toloza, Leonardo Bautista; Rodriguez, Edith Johana; de Salazar, Dora Ines Molina; Rodríguez, Camilo A; Sprinz, Eduardo; Cerbino-Neto, José; Luz, Kleber Giovanni; Schwarzbold, Alexandre Vargas; Paiva, Maria Sanali; Carlos, Josefina; Montellano, May Emmeline B; de Los Reyes, Mari Rose A; Yu, Charles Y; Alberto, Edison R; Panaligan, Mario M; Salvani-Bautista, Milagros; Buntinx, Erik; Hites, Maya; Martinot, Jean-Benoit; Bhorat, Qasim E; Badat, Aysha; Baccarini, Carmen; Hu, Branda; Jurgens, Jaco; Engelbrecht, Jan; Ambrosino, Donna; Richmond, Peter; Siber, George; Liang, Joshua; Clemens, Ralf.
Afiliação
  • Bravo L; University of the Philippines Manila, Ermita, Manila, Philippines.
  • Smolenov I; Clover Biopharmaceuticals, Cambridge, MA, USA.
  • Han HH; Clover Biopharmaceuticals, Cambridge, MA, USA.
  • Li P; Clover Biopharmaceuticals, Cambridge, MA, USA.
  • Hosain R; Clover Biopharmaceuticals, Cambridge, MA, USA.
  • Rockhold F; Duke University Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
  • Clemens SAC; Oxford Vaccine Group, University of Oxford, Oxford, UK.
  • Roa C; Manila Doctors Hospital, Manila, Philippines.
  • Borja-Tabora C; Asian Hospital and Medical Center, Alabang, Muntinlupa, Philippines.
  • Quinsaat A; Global Research in Infectious Diseases, Singapore.
  • Lopez P; Centro de Estudios en Infectología Pediátrica, Universidad Del Valle Clínica Imbanaco, Cali, Colombia.
  • López-Medina E; Centro de Estudios en Infectología Pediátrica, Universidad Del Valle Clínica Imbanaco, Cali, Colombia.
  • Brochado L; Clinica De La Costa, Barranquilla, Atlantico, Colombia.
  • Hernández EA; Hospital Universidad del Norte, Barranquilla, Colombia.
  • Reynales H; Center of Attention in Medical Research, Bogotá, Colombia.
  • Medina T; Center of Attention in Medical Research, Bogotá, Colombia.
  • Velasquez H; Center of Attention in Medical Research, Bogotá, Colombia.
  • Toloza LB; Center of Attention in Medical Research, Bogotá, Colombia.
  • Rodriguez EJ; Center of Attention in Medical Research, Bogotá, Colombia.
  • de Salazar DIM; Faculty of Health Sciences at the University of Caldas, Manizales, Colombia.
  • Rodríguez CA; Policlínico Social del Norte, Bogotá, Colombia.
  • Sprinz E; Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Cerbino-Neto J; D'Or Institute for Research and Education, Rio de Janeiro, Brazil.
  • Luz KG; Federal University of Rio Grande do Norte, Natal, Brazil.
  • Schwarzbold AV; Infectious Diseases Division, Universidade Federal de Santa Maria, Rio Grande do Sul, Brazil.
  • Paiva MS; Atena Institute of Clinical Research, Rio Grande do Norte, Natal, Brazil.
  • Carlos J; University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines.
  • Montellano MEB; Far Eastern University Hospital - Nicanor Reyes Medical Foundation, Quezon City, Philippines.
  • de Los Reyes MRA; Las Pinas Doctors Hospital, Las Pinas City, Philippines.
  • Yu CY; De La Salle Medical and Health Sciences Institute, Cavite City, Philippines.
  • Alberto ER; Tropical Disease Foundation, Cavite City, Philippines.
  • Panaligan MM; Infection Control Service, St Luke's Medical Center, Taguig, Philippines.
  • Salvani-Bautista M; University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines.
  • Buntinx E; Anima Research Center, Alken, Belgium.
  • Hites M; Clinic of Infectious Diseases, CUB-Hôpital Erasme, Bruxelles, Belgium.
  • Martinot JB; Pulmonology Department, CHU Universite Catholique de Louvain Namur Site Sainte-Elisabeth, Namur, Belgium.
  • Bhorat QE; Soweto Clinical Trials Centre, Johannesburg, South Africa.
  • Badat A; Wits Clinical Research, Soweto, Johannesburg, South Africa.
  • Baccarini C; Clover Biopharmaceuticals, Cambridge, MA, USA.
  • Hu B; Clover Biopharmaceuticals, Cambridge, MA, USA.
  • Jurgens J; DJW Research, Noordheuwel, Krugersdorp, Gauteng, South Africa.
  • Engelbrecht J; Dr JM Engelbrecht Trial Site, Vergelegen Mediclinic, Western Cape, South Africa.
  • Ambrosino D; Independent Advisor, Stuart, FL, USA.
  • Richmond P; Division of Paediatrics, University of Western Australia, Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute and Perth Children's Hospital, Perth, WA, Australia.
  • Siber G; Independent Advisor, New York, NY, USA.
  • Liang J; Clover Biopharmaceuticals, Chengdu, China.
  • Clemens R; Global Research in Infectious Diseases, Rio de Janeiro, Brazil. Electronic address: clemens.ralf@outlook.com.
Lancet ; 399(10323): 461-472, 2022 01 29.
Article em En | MEDLINE | ID: mdl-35065705
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Africa / America do sul / Asia / Brasil / Colombia / Europa Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Filipinas País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Africa / America do sul / Asia / Brasil / Colombia / Europa Idioma: En Revista: Lancet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Filipinas País de publicação: Reino Unido